These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 79342)
21. Fundamental differences in the action of estrogens and antiestrogens on the uterus: comparison between compounds with similar duration of action. Katzenellenbogen BS; Ferguson ER; Lan NC Endocrinology; 1977 May; 100(5):1252-9. PubMed ID: 849722 [TBL] [Abstract][Full Text] [Related]
22. Dissociation of uterine eosinophilia and water imbibition from other estrogen-induced responses by nafoxidine pretreatment. Galand P; Tchernitchin N; Tchernitchin AN Mol Cell Endocrinol; 1985 Oct; 42(3):227-33. PubMed ID: 2412910 [TBL] [Abstract][Full Text] [Related]
23. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen. Katzenellenbogen BS; Ferguson ER Endocrinology; 1975 Jul; 97(1):1-12. PubMed ID: 166821 [TBL] [Abstract][Full Text] [Related]
24. Effect of nafoxidine (U-11,100A) on the induction of uterine peroxidase. McNabb T; Jellinck PH Steroids; 1976 May; 27(5):681-9. PubMed ID: 181872 [TBL] [Abstract][Full Text] [Related]
25. Specific binding and biological response of antiestrogens in the fetal uterus of the guinea pig. Gulino A; Pasqualini JR Cancer Res; 1980 Oct; 40(10):3821-6. PubMed ID: 7438065 [TBL] [Abstract][Full Text] [Related]
26. Effects of an anti-estrogen on neural estradiol binding and on behaviors in female rats. Wade GN; Blaustein JD Endocrinology; 1978 Jan; 102(1):245-51. PubMed ID: 743949 [No Abstract] [Full Text] [Related]
27. MER-25 and U-11, 100A, two antiestrogens with tissue-selective and incomplete estrogenic activity, on rat uterus. Ljungkvist I; Terenius L Contraception; 1974 Oct; 10(4):395-404. PubMed ID: 4452241 [No Abstract] [Full Text] [Related]
28. Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in MCF-7 human breast cancer cells. Horwitz KB; Aiginger P; Kuttenn F; McGuire WL Endocrinology; 1981 May; 108(5):1703-9. PubMed ID: 7194178 [No Abstract] [Full Text] [Related]
29. Antiestrogens: effects of tamoxifen, nafoxidine, and CI-628 on sexual behavior, cytoplasmic receptors, and nuclear binding of estrogen. Etgen AM Horm Behav; 1979 Oct; 13(2):97-112. PubMed ID: 399606 [No Abstract] [Full Text] [Related]
30. RNA polymerase activity and uterine growth: Differential stimulation by estradiol, estriol, and nafoxidine. Hardin JW; Clark JH; Glasser SR; Peck EJ Biochemistry; 1976 Apr; 15(7):1370-4. PubMed ID: 944048 [TBL] [Abstract][Full Text] [Related]
31. Differential blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine. Galand P; Mairesse N; Roorijck J; Flandroy L J Steroid Biochem; 1983 Sep; 19(3):1259-63. PubMed ID: 6194375 [TBL] [Abstract][Full Text] [Related]
32. [Biological action of estrogens and antiestrogens in the fetal uterus of the guinea pig: uterotrophic effect and action on progesterone receptors]. Pasqualini JR; Sumida C; Gulino A; Nguyen BL; Tardy J; Gelly C Pathol Biol (Paris); 1980 Jun; 28(6):383-4. PubMed ID: 6994047 [No Abstract] [Full Text] [Related]
33. The effect of clomid and other triphenylethylene derivatives during pregnancy and the neonatal period. Clark JH; McCormack SA J Steroid Biochem; 1980 Jan; 12():47-53. PubMed ID: 7421230 [No Abstract] [Full Text] [Related]
34. Nuclear association states of rat uterine oestrogen receptors as probed by nuclease digestion. Schoenberg DR; Clark JH Biochem J; 1981 May; 196(2):423-32. PubMed ID: 6274314 [TBL] [Abstract][Full Text] [Related]
35. Effects of tamoxifen, tamoxifen metabolites, and nafoxidine on adenosine 3',5'-monophosphate phosphodiesterase: correlations with growth inhibitory activities but not estrogen receptor affinities. Fanidi A; Courion-Guichardaz C; Fayard JM; Pageaux JF; Laugier C Endocrinology; 1989 Sep; 125(3):1187-93. PubMed ID: 2547579 [TBL] [Abstract][Full Text] [Related]
36. Induction of uterine ornithine decarboxylase (ODC) by antiestrogens. Inhibition of estradiol-mediated induction of ODC: a possible mechanism of action of antiestrogens. Bulger WH; Kupfer D Endocr Res Commun; 1976; 3(3-4):209-18. PubMed ID: 964206 [TBL] [Abstract][Full Text] [Related]
37. The role of intracellular equilibria and the effect of antiestrogens on estrogen-receptor dissociation kinetics from perfused cultures of human breast cancer cells. Strobl JS; Monaco ME; Lippman ME Endocrinology; 1980 Aug; 107(2):450-60. PubMed ID: 7389663 [No Abstract] [Full Text] [Related]
38. Time-related effects of a triphenylethylene antiestrogen on estrogen-induced changes in uterine weight, estrogen receptors, and endometrial sensitivity in rats. Trivedi RN; Chauhan SC; Dwivedi A; Kamboj VP; Singh MM Contraception; 1995 Jun; 51(6):367-79. PubMed ID: 7554978 [TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange. Markaverich BM; Williams M; Upchurch S; Clark JH Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414 [TBL] [Abstract][Full Text] [Related]
40. In vitro stimulation by estrogen of guanosine 3',5'-monophosphate accumulation in incubated rat uterus. Flandroy L; Galand P Endocrinology; 1980 Apr; 106(4):1187-92. PubMed ID: 6244144 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]